Jewell, EL, Darcy, KM, Hutson, A, Lee, PS, Havrilesky, LJ, Grace, LA, Berchuck, A, and Secord, AA. "Association between the N-terminally truncated (DeltaN) p63alpha (DeltaNp63alpha) isoform and debulking status, VEGF expression and progression-free survival in previously untreated, advanced stage epithelial ovarian cancer: A Gynecologic Oncology Group study." Gynecol Oncol 115, no. 3 (December 2009): 424-429.
Paula Sowon Lee, MD
Dr. Paula Lee is an Assistant Professor in the Division of Gynecologic Oncology at Duke University Medical Center. She received her undergraduate degree in Biology and Asian Studies from the University of Michigan and graduated with a combined medical degree with a Masters in Public Health from Tulane University. She completed her residency in Obstetrics and Gynecology and her fellowship in Gynecologic Oncology at Duke University Medical Center. Upon completing her oncology fellowship in 2007, she accepted a faculty position within the Division of Gynecologic Oncology at Duke.
Her research interests include therapeutic and surgical trials for gynecologic malignancies and improving end of life care. She is board certified in Gynecologic Oncology and Hospice and Palliative Medicine. She has successfully mentored residents and fellows in their research and clinical endeavors. She is also involved in global health initiatives and has interests in developing a sustainable training program in gynecologic oncology in sub-saharan African countries.
Education and Training
- Residency, Ob/Gyn, Duke University, 2000 - 2004
- M.D., Tulane University, 2000
Research interests include therapeutic and surgical trials for gynecologic malignancies and improving end of life care.
Selected Grants and Awards
Lee, PS, Bland, A, Valea, FA, Havrilesky, LJ, Berchuck, A, and Secord, AA. "Robotic-assisted laparoscopic gynecologic procedures in a fellowship training program." JSLS 13, no. 4 (October 2009): 467-472.
Horne, HN, Lee, PS, Murphy, SK, Alonso, MA, Olson, JA, and Marks, JR. "Inactivation of the MAL gene in breast cancer is a common event that predicts benefit from adjuvant chemotherapy." Mol Cancer Res 7, no. 2 (February 2009): 199-209.
Matsumura, N, Huang, Z, Baba, T, Lee, PS, Barnett, JC, Mori, S, Chang, JT, Kuo, W-L, Gusberg, AH, Whitaker, RS, Gray, JW, Fujii, S, Berchuck, A, and Murphy, SK. "Yin yang 1 modulates taxane response in epithelial ovarian cancer." Mol Cancer Res 7, no. 2 (February 2009): 210-220.
Bland, AE, Calingaert, B, Secord, AA, Lee, PS, Valea, FA, Berchuck, A, Soper, JT, and Havrilesky, L. "Relationship between tamoxifen use and high risk endometrial cancer histologic types." Gynecol Oncol 112, no. 1 (January 2009): 150-154.
Lee, PS, Bakelaar, R, Fitpatrick, CB, Ellestad, SC, Havrilesky, LJ, and Alvarez Secord, A. "Medical and surgical treatment of placenta percreta to optimize bladder preservation." Obstet Gynecol 112, no. 2 Pt 2 (August 2008): 421-424.
Schildkraut, JM, Moorman, PG, Bland, AE, Halabi, S, Calingaert, B, Whitaker, R, Lee, PS, Elkins-Williams, T, Bentley, RC, Marks, JR, and Berchuck, A. "Cyclin E overexpression in epithelial ovarian cancer characterizes an etiologic subgroup." Cancer Epidemiol Biomarkers Prev 17, no. 3 (March 2008): 585-593.
Lee, PS, Teaberry, V, Bland, AE, Huang, Z, Secord, AA, Berchuck, A, and Murphy, SK. "MAL, a gene associated with survival in epithelial ovarian cancer, is epigenetically regulated." March 2008.
Rubatt, JM, Darcy, KM, Hutson, A, Bean, SM, Havrilesky, LJ, Lee, PS, Grace, LA, Berchuck, A, and Secord, AA. "Prognostic relevance of microvessel density in previously untreated, advanced-stage epithelial ovarian cancer and associations between CD31, CD105, p53 status, and angiogenic marker expression: A Gynecologic Oncology Group study." March 2008.
Barnett, JC, Bland, A, Whitaker, R, Calingaert, B, Bentley, RC, Lee, PS, Moorman, PC, Schildkraut, JM, and Berchuck, A. "The prognostic significance of p53 and cyclin E overexpression in ovarian cancer: A population-based study." GYNECOLOGIC ONCOLOGY 108, no. 3 (March 2008): S125-S125.